PepGen Operating Income Growth & History (PEPG)
PepGen's operating income was −$93.6M for fiscal 2025.
View full PepGen company overviewPepGen annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$93.6M | $4.1M | — |
| 2024 | 2024-12-31 | −$97.7M | −$13.0M | — |
| 2023 | 2023-12-31 | −$84.8M | −$16.5M | — |
| 2022 | 2022-12-31 | −$68.3M | −$41.2M | — |
| 2021 | 2021-12-31 | −$27.1M | — | — |
PepGen quarterly operating income
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$18.9M | $5.0M | — |
| Q1 2026 | 2026-03-31 | −$18.9M | $12.4M | — |
| Q4 2025 | 2025-12-31 | −$19.7M | $4.6M | — |
| Q3 2025 | 2025-09-30 | −$18.7M | $4.5M | — |
| Q2 2025 | 2025-06-30 | −$23.9M | $6.5M | — |
| Q1 2025 | 2025-03-31 | −$31.3M | −$11.5M | — |
| Q4 2024 | 2024-12-31 | −$24.3M | −$3.5M | — |
| Q3 2024 | 2024-09-30 | −$23.2M | $1.6M | — |
| Q2 2024 | 2024-06-30 | −$30.4M | −$9.3M | — |
| Q1 2024 | 2024-03-31 | −$19.8M | −$1.8M | — |
| Q4 2023 | 2023-12-31 | −$20.8M | −$3.6M | — |
| Q3 2023 | 2023-09-30 | −$24.8M | −$5.2M | — |
| Q2 2023 | 2023-06-30 | −$21.1M | −$3.5M | — |
| Q1 2023 | 2023-03-31 | −$18.0M | −$4.1M | — |
| Q4 2022 | 2022-12-31 | −$17.2M | −$10.0M | — |
| Q3 2022 | 2022-09-30 | −$19.6M | −$11.5M | — |
| Q2 2022 | 2022-06-30 | −$17.6M | −$12.4M | — |
| Q1 2022 | 2022-03-31 | −$13.9M | −$7.3M | — |
| Q4 2021 | 2021-12-31 | −$7.2M | — | — |
| Q3 2021 | 2021-09-30 | −$8.1M | — | — |
| Q2 2021 | 2021-06-30 | −$5.2M | — | — |
| Q1 2021 | 2021-03-31 | −$6.6M | — | — |
PepGen operating income trends
Between the periods ended 2021-12-31 and 2025-12-31, PepGen's operating income decreased from −$27.1M to −$93.6M, a change of −$66.5M. The latest reported quarter, Q2 2026, shows −$18.9M.
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PepGen source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...